MIT scientists have achieved the first-ever lab synthesis of verticillin A, a complex fungal compound discovered in 1970. Its delicate structure stalled chemists for decades, despite differing from related molecules by only two atoms. With the synthesis finally complete, researchers created new variants that showed strong activity against a rare pediatric brain cancer. The breakthrough could unlock an entire class of previously unreachable cancer-fighting molecules.

New research suggests Alzheimer’s may start far earlier than previously thought, driven by a hidden toxic protein in the brain. Scientists found that an experimental drug, NU-9, blocks this early damage in mice and reduces inflammation linked to disease progression. The treatment was given before symptoms appeared, targeting the disease at its earliest stage. Researchers say this approach could reshape how Alzheimer’s is prevented and treated.

How you walk may matter just as much as how much you walk. A large UK study tracking more than 33,000 low-activity adults found that people who grouped their daily steps into longer, uninterrupted walks had dramatically lower risks of early death and heart disease than those who moved in short, scattered bursts.

A new study shows dopamine isn’t the brain’s movement “gas pedal” after all. Instead of setting speed or strength, it quietly enables movement in the background, much like oil in an engine. When scientists manipulated dopamine during movement, nothing changed—but restoring baseline dopamine levels made a big difference. The finding could reshape how Parkinson’s disease is treated.

A Brazilian study has confirmed that Joseph’s Coat, a plant used for generations in folk medicine, can significantly reduce inflammation and arthritis symptoms in lab tests. Researchers observed less swelling, healthier joints, and signs of tissue protection. Just as important, the extract showed a promising safety profile at tested doses. The discovery could pave the way for new plant-based anti-inflammatory treatments.